May 7, 2020 / 12:43 PM / 22 days ago

BRIEF-ANI Pharmaceuticals Reports Q1 2020 Results And Appoints Interim CEO

May 7 (Reuters) - ANI Pharmaceuticals Inc:

* ANI PHARMACEUTICALS REPORTS FIRST QUARTER 2020 RESULTS AND APPOINTS INTERIM CEO

* Q1 ADJUSTED NON-GAAP EARNINGS PER SHARE $1.04

* Q1 GAAP LOSS PER SHARE $0.59

* Q1 REVENUE $49.8 MILLION VERSUS REFINITIV IBES ESTIMATE OF $50.2 MILLION

* Q1 EARNINGS PER SHARE ESTIMATE $0.89 — REFINITIV IBES DATA

* SUSPENDS GUIDANCE FOR 2020

* IS CURRENTLY CONDUCTING SEARCH FOR A PRESIDENT AND CEO Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below